Attempts to elucidate the genomic profile of this rare tumor have been accomplished by only a few studies, but have emphasized the involvement of PDGFRA, a gene encoding tyrosine kinase receptors for platelet-derived growth factor. Here, PDGFRA is linked to neoplasm.